About: Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 September 1996

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у вересні 1996 (uk) article scientifique publié en 1996 (fr) im September 1996 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en setiembre de 1996 (ast) scientific article published on 01 September 1996 (en) գիտական հոդված հրատարակված 1996 թվականի սեպտեմբերի 1-ին (hy)
publication date	wds:Q71512897-DEBA0098-7419-4301-9B66-471BE235E335
publication date	1996-09-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q71512897-AA397658-E6E8-4B4F-A988-86C2244E2848
language of work or name	English
author name string	wds:Q71512897-03FEA50A-8C30-497A-951F-1514FF356121 wds:Q71512897-0C61C176-F4FE-463B-885C-0A2547D7E297 wds:Q71512897-352BCF10-B894-4B20-9203-D82546F9F1A5 wds:Q71512897-7EEA4963-77AD-4D41-AD5C-78CBE3B93555 wds:Q71512897-7F629292-FC18-4511-8D15-5FCB0F2BDF16 wds:Q71512897-8DE768DC-0D37-41D0-8A50-B17D3686EB42 wds:Q71512897-A48FD58F-07EE-494B-8783-15C46DBC6905 wds:Q71512897-E3EC76B4-D260-4323-AE6F-BBDE388B2221
author name string	J Newsom-Davis M L Lee A Vincent S A Misbah B Lang P G Bain H M Chapel M Motomura
rdfs:label	Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome (en) Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome (nl)
skos:prefLabel	Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome (en) Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome (nl)
name	Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome (en) Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome (nl)
title	wds:Q71512897-A1F04080-AF76-4B98-ADCB-508749439417
title	Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome (en)
page(s)	wds:Q71512897-4AFE1EA4-BBAB-480A-B659-6E2426CE0999
page(s)	678-683
instance of	wds:Q71512897-1FA77B95-B06B-4FB8-95A0-AF41E8EDFBC0
instance of	scholarly article
main subject	wds:Q71512897-0F9C4DF0-9D38-4E24-9513-4449A2AEE0B7 wds:Q71512897-E1D472AE-BC23-4F75-91CD-820E438B1B7D
main subject	muscle weakness Lambert-Eaton myasthenic syndrome
PubMed ID	wds:Q71512897-3410C0A8-8D2C-416C-AD58-F993D377FC64
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8797464
PubMed ID	8797464
published in	wds:Q71512897-75EDDF32-F206-4591-9607-A41C33EE465C
published in	Neurology
issue	wds:Q71512897-ACC738D9-1934-4ECD-A834-DF7E8BFBD9FA
volume	wds:Q71512897-D5667103-EF35-448A-81FC-48ABCB8B4729
issue	3
volume	47
DOI	wds:Q71512897-C623D557-1661-4A4F-8FD5-364814180BF1
DOI	http://dx.doi.org/10.1212/WNL.47.3.678
DOI	10.1212/WNL.47.3.678
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q71512897
is cites work of	Treatment for Lambert-Eaton myasthenic syndrome Benefits of glatiramer acetate on disability in relapsing-remitting multiple sclerosis. An analysis by area under disability/time curves. The Copolymer 1 Multiple Sclerosis Study Group Paraneoplastic Syndromes Involving the Nervous System Intravenous immunoglobulin: an update on the clinical use and mechanisms of action. Clinical uses of intravenous immunoglobulin. IVIg in myasthenia gravis, Lambert Eaton myasthenic syndrome and inflammatory myopathies: current status Intravenous immunoglobulin in neurological disease: a specialist review. Paraneoplastic neurologic syndromes [Use of i.v. immunoglobulins in neurology. Evidence-based consensus] Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. Neurologic paraneoplastic syndromes Paraneoplastic syndromes: an approach to diagnosis and treatment Lambert-Eaton myasthenic syndrome and solitary cerebellar metastasis in a patient with occult small-cell lung cancer: a rare experience Paraneoplastic syndromes associated with lung cancer Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapy Lambert-Eaton Myasthenic Syndrome Remote neurologic manifestations of cancer Intravenous immunoglobulin in neurology--mode of action and clinical efficacy Evidence for the use of intravenous immunoglobulins--a review of the literature Efficacy of Intravenous Immunoglobulin in Neurological Diseases. Treatment for Lambert-Eaton myasthenic syndrome Autoimmune channelopathies: well-established and emerging immunotherapy-responsive diseases of the peripheral and central nervous systems Paraneoplastic syndromes of the neuromuscular junction: therapeutic options in myasthenia gravis, lambert-eaton myasthenic syndrome, and neuromyotonia. Treatment for Lambert-Eaton myasthenic syndrome Lambert-eaton myasthenic syndrome Update on treatment options for Lambert-Eaton myasthenic syndrome: focus on use of amifampridine Intravenous immunoglobulin treatment of neurological autoimmune diseases Simulation of monoclonal antibody pharmacokinetics in humans using a minimal physiologically based model Intravenous immunoglobulin therapy in paraneoplastic neurological syndromes Contactin-1 and Neurofascin-155/-186 Are Not Targets of Auto-Antibodies in Multifocal Motor Neuropathy Can intravenous immunoglobulin improve antibody-mediated botulinum toxin therapy failure? Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society Clinical applications of immunoglobulin: update Rapid and reversible responses to IVIG in autoimmune neuromuscular diseases suggest mechanisms of action involving competition with functionally important autoantibodies The Lambert-Eaton myasthenic syndrome Lambert-Eaton myasthenic syndrome Lambert-Eaton myasthenic syndrome Protective role of anti-idiotypic antibodies in autoimmunity--lessons for type 1 diabetes Paraneoplastic Diseases of the Nervous System Intravenous immunoglobulin therapy in neurological diseases during pregnancy Synaptic Pathophysiology and Treatment of Lambert-Eaton Myasthenic Syndrome Lambert-Eaton myasthenic syndrome (LEMS): a rare autoimmune presynaptic disorder often associated with cancer La place des immunoglobulines intraveineuses en neurologie

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software